Drug Approval | January 31, 2024
Enhertu granted Priority Review in the US for patients with metastatic HER2-positive solid tumours
Submission to be reviewed under FDA real-time oncology review and Project Orbis
Submission to be reviewed under FDA real-time oncology review and Project Orbis
PharmaLogic will assist ARTBIO with radiochemistry and supply of the finished radiopharmaceutical product for future Phase I and II clinical trials of AB001 from their facility in New York
India’s First Integrated Ayush Wellness Centre to come up in Guwahati, foundation stone laid
The R&D centre is mainly dedicated to the Process R&D of New Chemical Entities (NCE) development projects
Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
The Regional Reference Laboratory in Chennai is equipped with cutting-edge diagnostic technologies
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
Subscribe To Our Newsletter & Stay Updated
